Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by elgin1on May 26, 2020 1:58pm

95 Views

Post# 31074011

RE:RE:Sanofi-paragraph 3 "end it's hunt..." ???

elgin1 wrote: D

Hopefullinvesto wrote: https://www.bnnbloomberg.ca/sanofi-to-sell-regeneron-stake-worth-about-13-billion-1.1440807

Yes Sanofi is moving away from traditional oral drugs for diabetes. They realize the new game is gene and cell therapy. They have in fact spent lots of money on diabetes stem cell reasearch . Follow the money. They are in advanced stages with the B cell for diabetes hence they are not going to waste money on drug research when they can have stem cells that are a cure for diabetes.

https://www.evotec.com/en/invest/news--announcements/press-releases/p/evotec-achieves-third-milestone-in-cell-therapy-diabetes-alliance-with-sanofi-5885

They have made incredible progress with B cells. Follow the money. I am guessing they might need some device too . They have a new CEO Peter Hudson who was former head at Novartis . Sanofi owns Bioveraativ Hemophilia but they are advancing the stem cell program with diabetes.

Hopefull investor you aren’t Bioteck with a different handle by any chance . You have the same MO subtle negative jibes at crucial times . I smell a rat. Woof woof

Bullboard Posts

Eminent acquires promising Nevada gold project